INfluenza Vaccine to Effectively Stop cardioThoracic Events and Decompensated heart failure Trial
The INVESTED Trial is designed to determine which of two formulations of influenza vaccine, the standard dose or an investigational higher dose, is more effective in reducing deaths and heart- or lung-related admissions to the hospital.
Influenza and Heart Disease
Influenza "flu" can lead to complications like hospitalizations and/or death, particularly in individuals with heart disease. In fact, influenza-related death is more common in people with heart disease than any other chronic health condition.